2021 TAAIS Annual Meeting

April 23, 2021 to April 25, 2021

The 2021 TAAIS Annual Meeting, spanning three half-days, will offer state-of-the-art advances in allergic, asthmatic and immunologic diseases. Nationally renowned experts from across the U.S. will engage the practicing allergist/immunologist and discuss the most challenging problems in patients with allergies, asthma and immunodeficiencies. In addition, Allergy fellows-in-training will provide a first-hand snapshot of the exciting allergy/immunology research going on in the State of Texas.

This will be a live, online meeting using a virtual event platform. Registered attendees will use the email address they registered with to log into the platform on the days of the meeting. The meeting will include live presentations with audience participation and will also be available on-demand for 3 months after the original meeting dates.
For questions, please contact Connie Mawer at (512) 451-6108 or cmawer@taais.org

Registration fees:

Member TypeFee
TAAIS Member (physicians & allied health)FREE
A/I Fellows-in-TrainingFREE
Non-TAAIS Member$200


Target Audience

  • A/I physicians
  • A/I Fellows-in-Training
  • PhDs
  • PharmDs
  • Nurse Practitioners and Physician Assistants


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Manage chronic rhinosinusitis with nasal polyps and assess when (and if) such patients should be referred to the otolaryngologist for surgical options.
  • Describe morphologic features of several conditions that mimic atopic dermatitis.
  • Recognize the heterogeneity of mast cell activation syndromes and understand the rationale of applying the consensus diagnostic criteria.
  • Explain the anatomical approach to the evaluation of a patient with chronic cough.
  • Review the role of allergic and non-allergic rhinitis, and chronic rhinosinusitis in chronic cough.
  • Describe some of the common genetic techniques utilized in diagnosis and management of primary immunodeficiency and provide some guidelines for interpretation of variants identified by genetic testing.
  • Discuss the latest classification of mastocytosis and formulate treatment options for different disease categories.
  • Describe recent coding changes, biologic billing changes, and changes in allergy practices post COVID-19.
  • Identify good candidates for oral food challenges in the office based on clinical history, testing, and potential benefits of tolerating the food.
  • Describe the role played by the AMA working with other medical societies to advocate for physicians and their patients.
  • Discuss ways to successfully support legislative efforts that impact the practice of allergy, asthma, and immunology.

Additional Information

Available credit: 
  • 10.00 Attendance
    Attendance credit.
  • 10.00 CME
    CME credit.
Course opens: 
Course expires: 
Event starts: 
04/23/2021 - 12:00pm CDT
Event ends: 
04/25/2021 - 12:00pm CDT


Friday – Sunday, April 23-25, 2021

David A. Khan, MD, UT Southwestern Medical Center, Dallas, TX


12:00 pm    Product Theater Non-CME / Break with Exhibitors

12:30 pm    David A. Khan, MD Honorary Lecture:  Update on Rhinosinusitis
        Anju Peters, MD, MSCI, Northwestern University, Chicago, IL 
1:30 pm    Mimics of Atopic Dermatitis including Contact Dermatitis
Neill T. Peters, MD, Medical Dermatology Associates of Chicago, IL 

2:30 pm    Amgen/AstraZeneca TSLP Product Theater Non-CME / Break with Exhibitors
3:00 pm     Andrew Grant, MD Honorary Lecture:  Mast Cell Activation Syndrome
Cem Akin, MD, PhD, University of Michigan Medical Center, Ann Arbor, MI 

4:00 pm     An Approach to Chronic Cough
Kaiser G. Lim, MD, Mayo Clinic, Rochester, MN 

5:00 pm    Adjourn


8:00 am    Product Theater Non-CME / Break with Exhibitors

8:30 am    William T. Shearer, MD, PhD Memorial Lecture:  Understanding Genetic Testing in Primary Immunodeficiency 
Troy R. Torgerson, MD, PhD, Allen Institute for Immunology, Seattle, WA 

9:30 am    Mastocytosis 
Cem Akin, MD, PhD, University of Michigan Medical Center, Ann Arbor, MI 

10:30 am    AstraZeneca Fasenra Product Theater Non-CME / Break with Exhibitors

11:00 am    15-Minute Presentations by Allergy Fellows-in-Training

Blaptica dubia IgE Mediated Hypersensitivity in an Adult Dubia Roach Breeder
Jun Mendoza, Maj, MD, Wilford Hall Medical Center, San Antonio, TX

Subcutaneous Immunotherapy in Patients with Severe Asthma: Outcomes from a Multi-center Private Practice Allergy Group
Timothy Chow, MD, UT Southwestern Medical Center, Dallas, TX

Impulse Oscillometry as Predictor of Asthma exacerbation resulting in Emergency Room/Urgent Care Visits or Hospitalization: A Retrospective Study
Jose E. Rojas Camayo, MD, UT Medical Branch, Galveston, TX

A Monogenic Cause of Infantile-Onset Inflammatory Bowel Disease
Natalia Chaimowitz, MD, Baylor College of Medicine, Houston, TX

12:00 pm    TAAIS Annual Business Meeting

1:00 pm    Adjourn


8:00 am    Product Theater Non-CME / Break with Exhibitors

8:30 am    Oral Food Challenges in the Office
Stephanie A. Leonard, MD, UC San Diego School of Medicine, San Diego, CA

9:30 am    The Future of Medicine & the Role of Advocacy (Ethics/Prof Responsibility) 
Susan Bailey, MD; Louise Bethea, MD; Stuart Abramson, MD, PhD 

10:30 am    Product Theater Non-CME / Break with Exhibitors

11:00 am    Hot Topics in Practice Management:  Updates for 2021
Priya Bansal, MD, Asthma and Allergy Wellness Center, St. Charles, IL

12:00 pm    Adjourn



Planning Committee

J. Andrew Bird, MD FAAAAI
University of Texas Southwestern Medical Center, Dallas, TX
Relevant relationships: Before Brands, DBV Technologies (consultant); AllerGenis, Allergy Therapeutics, Ltd, Genentech, Prota Therapeutics (advisory board); Aimmune Therapeutics, Astellas, DBV Technologies, FARE, Genentech, NIH-NIAID (research grant)

David Khan, MD FAAAAI
University of Texas Southwestern Medical Center, Dallas, TX
Relevant relationships: Aimmune (advisory board)

William Lumry, MD FAAAAI
Allergy and Asthma Specialists, Dallas, TX
Relevant relationships: Adverum, BioCryst, CSL Behring, Optum RX, Pharming (consultant); ALK, Attenua, BioCryst, Genetech , Gossamer, Green Cross, GSK, Ionis, Kedrion, Menlo, NeRRE, Novartis, Octapharma, Pearl, Sanofi, Teva/Watson (research grant); CSL Behring, Genetech, Optinose, Sanofi-Regeneron, Shire (speaker); Shire (advisory board)

Vivek Rao, MD
Advanced Allergy and Asthma Care, Odessa, TX
Relevant relationships: TBA


Stuart Abramson, MD PhD AE-C FAAAAI
Shannon Medical Center/Shannon Clinic, San Angelo, TX
Relevant relationships: None

University of Michigan, Ann Arbor, MI
Relevant relationships: Novartis, Blueprint (consultant)

Susan Rudd Bailey, MD FAAAAI
Fort Worth Allergy and Asthma Associates, Fort Worth, TX
Relevant relationships: None

Priya J. Bansal, MD FAAAAI
Asthma and Allergy Wellness Center, St. Charles, IL
Relevant relationships: ALK, Astra Zeneca, CSL Behring, Regeneron, Takeda (speaker); Pharming (advisory board)

Louise Bethea, MD FAAAAI
Allergy, Asthma & Immunology Care Center, The Woodlands, TX
Relevant relationships: None

Jose Rojas Chamayo, MD
UTMB, Galveston, TX
Relevant relationships: None

Natalia Chaimowitz, MD
Baylor College of Medicine, Houston, TX
Relevant relationships: None

Timothy Chow, MD
University of Texas Southwestern, Dallas, TX
Relevant relationships: None

Stephanie Leonard, MD FAAAAI
Rady Children's Hospital/UCSD, San Diego, CA
Relevant relationships: Aimmune Therapeutics, DBV Technologies (site principle investigator)

Northwestern University Medical School, Chicago, IL
Relevant relationships: Sanofi Regeneron, Astra Zeneca (consultant); Astra Zeneca, Optinose (research grant); GSK (advisory board)

Neill Peters, MD
Medical Dermatology Associates of Chicago, Chicago, IL
Relevant relationships: None

Troy Torgerson, MD PhD
Seattle Children's Research Institute, Seattle, WA
Relevant relationships: CSL Behring, Enzyvant, Grifols, Takeda, X4 Pharmaceuticals (consultant); NIH (research grant)

Content Reviewer

Anne Borgmeyer, RN CPNP AE-C
St. Louis Childrens Hospital, St. Louis, MO
Relevant relationships: None

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Texas Allergy, Asthma & Immunology Society. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.

AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Activity-related questions should be directed to Connie Mawer at cmawer@taais.org.

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 10.00 Attendance
    Attendance credit.
  • 10.00 CME
    CME credit.


Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Microsoft Explorer, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.